4,794 Shares in Chemed Co. (NYSE:CHE) Acquired by C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors

C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in shares of Chemed Co. (NYSE:CHE) in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 4,794 shares of the company’s stock, valued at approximately $2,540,000.

Other large investors have also recently added to or reduced their stakes in the company. Van ECK Associates Corp boosted its holdings in shares of Chemed by 30.4% during the fourth quarter. Van ECK Associates Corp now owns 15,141 shares of the company’s stock valued at $8,022,000 after acquiring an additional 3,531 shares during the period. Allspring Global Investments Holdings LLC lifted its position in Chemed by 9.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 46,052 shares of the company’s stock valued at $24,314,000 after purchasing an additional 3,785 shares during the last quarter. Schwartz Investment Counsel Inc. boosted its stake in Chemed by 1.0% during the 4th quarter. Schwartz Investment Counsel Inc. now owns 119,163 shares of the company’s stock valued at $63,133,000 after purchasing an additional 1,173 shares during the period. Portfolio Design Labs LLC bought a new position in Chemed in the 4th quarter worth about $324,000. Finally, Elevate Capital Advisors LLC acquired a new stake in shares of Chemed in the fourth quarter valued at approximately $1,106,000. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

CHE has been the subject of several analyst reports. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada cut their target price on Chemed from $697.00 to $633.00 and set an “outperform” rating on the stock in a research note on Tuesday, November 5th.

Insider Transactions at Chemed

In other news, VP Brian C. Judkins bought 145 shares of the firm’s stock in a transaction that occurred on Monday, December 30th. The stock was acquired at an average price of $519.50 per share, with a total value of $75,327.50. Following the completion of the purchase, the vice president now directly owns 1,678 shares of the company’s stock, valued at $871,721. This represents a 9.46 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of Chemed stock in a transaction dated Monday, November 25th. The stock was sold at an average price of $572.77, for a total value of $1,145,540.00. Following the transaction, the chief executive officer now directly owns 101,735 shares in the company, valued at approximately $58,270,755.95. The trade was a 1.93 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 3.32% of the company’s stock.

Chemed Stock Down 0.8 %

Shares of CHE opened at $549.51 on Thursday. The firm has a market capitalization of $8.27 billion, a PE ratio of 27.77, a P/E/G ratio of 2.16 and a beta of 0.48. The firm has a 50-day moving average price of $542.24 and a 200 day moving average price of $564.74. Chemed Co. has a 52-week low of $512.12 and a 52-week high of $654.62.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.